2011 to 2017 Saw Increase in Spending on DMTs for MS

WEDNESDAY, Jan. 15, 2020 -- From 2011 to 2017, there was an increase in gross annual expenditures on multiple sclerosis (MS) disease-modifying therapies (DMTs), with increased spending mainly driven by increases in per-prescription costs, according...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news